Latest Venus Remedies stock price

Venus Remedies P/E Ratio

VENUSREM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
11.99
Low Valuation
Low - May indicate good value opportunity

Current Valuation Metrics

P/E Ratio 11.99
Current Price ₹756.05
EPS (TTM) ₹33.90
Exchange NSE

Valuation Signal

Signal Undervalued
Historical Avg 12.28
Historical Range 6.96 - 18.69
Percentile 40.0%

Sector Context

Sector Average 48.27
Sector Median 27.37
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹57.09
Sept 2025 ₹15.06
Mar 2025 ₹15.71

Key P/E Ratio Insights for Venus Remedies

  • Stock appears undervalued with PE of 11.99, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 48.27

View the VENUSREM equity price for detailed stock performance.

P/E Ratio Historical Trend for Venus Remedies

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 8.11 57.09 ₹462.75 NSE Low
2024 12.28 26.07 ₹320.15 BSE Low
2023 18.69 21.72 ₹405.95 BSE Moderate
2022 15.38 11.78 ₹181.15 BSE Moderate
2021 6.96 58.85 ₹409.60 BSE Low

Sector P/E Ratio Comparison

Comparing Venus Remedies with other companies in Healthcare sector
Sector Average
48.27
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low